Pharmacopsychiatry

Papers
(The median citation count of Pharmacopsychiatry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels126
Review and Consensus on Pharmacogenomic Testing in Psychiatry105
The History of Psychedelics in Psychiatry70
Classic Psychedelic Drugs: Update on Biological Mechanisms41
Psychedelics and Psychotherapy37
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders34
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports32
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review23
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry16
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease16
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States15
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future15
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice15
Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties15
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update14
Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases13
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response13
COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine12
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?12
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs11
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials10
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties10
Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus10
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study10
Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders9
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study9
Baseline Working Memory Predicted Response to Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression9
Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway8
Expression Biomarkers of Pharmacological Treatment Outcomes in Women with Unipolar and Bipolar Depression8
Anti-SARS-CoV-2 Action of Fluvoxamine may be Mediated by Endothelial Nitric Oxide Synthase8
Impact of Psychiatric and Related Somatic Medications on the Duration and Severity of COVID-19: A Retrospective Explorative Multi-center Study from the German M7
Psychedelics: A New Treatment Paradigm in Psychiatry?6
Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age6
Sex-specific Association of Antipsychotic-induced Weight Gain and Treatment Response for Antipsychotic-Naive First Episode Schizophrenia Patients: A Prospective 8-week Longitudinal Study6
Digital Phenotyping and Mobile Sensing in Addiction Psychiatry5
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population5
Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study5
Association between Adherence to SSRI Treatment and Mortality among Individuals with Metabolic Syndrome Components5
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature5
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review5
Robustly High Hippocampal BDNF levels under Acute Stress in Mice Lacking the Full-length p75 Neurotrophin Receptor4
Are Persons Treated with Antidepressants and/or Antipsychotics Possibly Better Protected against Severe COVID 19?4
Treatment Goals for Patients with Schizophrenia — A Narrative Review of Physician and Patient Perspectives4
COVID-19 Prognosis in Association with Antidepressant Use4
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy4
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS4
Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia3
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integratio3
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders3
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study3
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram3
Life-time Actionable Pharmacogenetic Drug Use: A Population-based Cohort Study in 86 040 Young People With and Without Mental Disorders in Denmark3
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring3
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review3
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study3
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial2
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial2
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study2
5-HTTLPR-rs25531 and Antidepressant Treatment Outcomes in Korean Patients with Major Depression2
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA2
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report2
Metformin is Protective Against the Development of Mood Disorders2
Implications of Online Self-Diagnosis in Psychiatry2
Morphological Representation of C1q in the Aging Central Nervous System2
Association between Adherence with an Atypical Antipsychotic and with Other Psychiatric Drugs in Patients with Bipolar Disorder2
Overview: Chronic Pain and Cannabis-Based Medicines2
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review2
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism1
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report1
Withanone Ameliorates Stress Symptoms in Caenorhabditis Elegans by Acting through Serotonin Receptors1
Comparison of Sodium Lactate Infusion and Carbon Dioxide Inhalation Panic Provocation Tests: A Meta-analysis1
Clozapine-Induced Stuttering: Case Report and Literature Review1
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients1
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation1
Cannabinoids for Behavioral Symptoms in Dementia: An Overview1
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab1
Alterations in BDNF Protein Concentrations in the Hippocampus do not Explain the Pro-Neurogenic Effect of Citalopram on Adult Neurogenesis1
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey1
Lithium Therapy in Old Age: Recommendations from a Delphi Survey1
Failing Memory in Nonaffective Psychosis and Prolactin Response to 12.5 µg i.v. TRH1
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response1
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics1
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D1
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine 1
A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection1
Effects of Discontinuation of Drugs Used for Augmentation Therapy on Treatment Outcomes in Depression: A Systematic Review and Meta-analysis1
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation1
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis1
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany1
0.4462730884552